Zobrazeno 1 - 10
of 648
pro vyhledávání: '"Eamonn Martin Quigley"'
Autor:
David Avelar Rodriguez, Paul MacDaragh Ryan, Erick Manuel Toro Monjaraz, Jaime Alfonso Ramirez Mayans, Eamonn Martin Quigley
Publikováno v:
Frontiers in Pediatrics, Vol 7 (2019)
Small intestinal bacterial overgrowth (SIBO) is a heterogenous and poorly understood entity characterised by an excessive growth of select microorganisms within the small intestine. This excessive bacterial biomass, in turn, disrupts host physiology
Externí odkaz:
https://doaj.org/article/6c1a4a4e4a384adc8c4cd05c5f46e3d8
Autor:
Imran Aziz, Eamonn Martin Quigley, Douglas A. Drossman, William E. Whitehead, Ami D. Sperber, Edith N. Okeke, Tamar Freud, Max Schmulson, John Kellow, Rutaba Khatun, Peter J. Whorwell, Shrikant I. Bangdiwala, Dan L. Dumitrascu, Magnus Simren, Olafur S. Palsson, Shin Fukudo, Xuicai Fang, Uday C Ghoshal, Jan Tack
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:e945-e956
BACKGROUND AND AIMS: Conditions such as irritable bowel syndrome (IBS), functional dyspepsia, and functional constipation are among the prevalent gastrointestinal (GI) disorders classified as disorders of gut-brain interaction (DGBI), which can adver
Autor:
Nehal N. Mehta, Isaac Acquah, Miguel Cainzos-Achirica, Hassan Syed Zawahir, Tamer Yahya, Bincy Abraham, Khurram Nasir, Kerri Glassner, Tanushree Agrawal, Eamonn Martin Quigley, Amit K. Dey
Publikováno v:
Journal of the American College of Cardiology. 76:2895-2905
Chronic inflammatory diseases including human immunodeficiency virus infection, psoriasis, rheumatoid arthritis, and systemic lupus erythematosus predispose to atherosclerotic cardiovascular disease (ASCVD). Inflammatory bowel disease (IBD) is a comm
Autor:
Eamonn Martin Quigley
Publikováno v:
Current Opinion in Gastroenterology. 37:39-43
Purpose of review Irritable bowel syndrome (IBS) is a very common disorder whose clinical presentation varies considerably between patients as well as within the same individual over time. Many of its symptoms, such as pain, diarrhea, constipation an
Autor:
David S Sanders, Nevin Oruc, Caroline J Tuck, Yeong Yeh Lee, Anton Le Mair, Govind K. Makharia, Cihan Yurdaydin, Tarkan Karakan, Eamonn Martin Quigley, Lyndal Collins, Peter R. Gibson, Julio C. Bai, Jane G. Muir
[No Abstract Available]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75cab4981a7373348d6bb2ad350b6bf1
https://avesis.gazi.edu.tr/publication/details/127b5333-f2fa-4bf8-8e41-6c6ae1baa54e/oai
https://avesis.gazi.edu.tr/publication/details/127b5333-f2fa-4bf8-8e41-6c6ae1baa54e/oai
Publikováno v:
Digestive Diseases and Sciences. 66:2345-2352
Frequent observation of abnormal manometric patterns consistent with dyssynergia in healthy volunteers has warranted the need for reassessment of the current methods to enhance the diagnostic value of anorectal manometry in functional defecatory diso
Publikováno v:
Current Opinion in Gastroenterology. 36:141-146
PURPOSE OF REVIEW Cancer cachexia is a complex condition that occurs in approximately 50% of cancer patients and in 80% of those with advanced cancer. It is characterized by lean body mass loss, adipose tissue loss, altered metabolism, increased infl
Publikováno v:
Indian Journal of Gastroenterology. 39:9-21
Evidence accumulates to implicate a role for the gut microbiota in non-alcoholic fatty liver disease (NAFLD)-a disorder that has reached almost epidemic proportions around the globe. For some time a disturbance in the gut microbiome, small intestinal
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:16-27
Inflammatory bowel disease (IBD) is a chronic immune-mediated disease affecting the gastrointestinal tract. IBD consists of 2 subtypes: ulcerative colitis and Crohn disease. IBD is thought to develop as a result of interactions between environmental,
Autor:
Nicholas E Burr, Michael Camilleri, Eamonn Martin Quigley, Pavit Luthra, Alexander C. Ford, Christopher J Black
Publikováno v:
The Lancet Gastroenterology & Hepatology. 4:831-844
Summary Background There are several drugs available for the treatment of chronic idiopathic constipation, but their relative efficacy is unclear because there have been no head-to-head randomised controlled trials. We did a network meta-analysis to